ClinicalTrials.Veeva

Menu

Challenges in Achieving Adequate Vitamin D Status in the Adult Population/ Part 2 (VITAD/2)

N

Nutrition Institute, Slovenia

Status

Completed

Conditions

Vitamin D Deficiency

Treatments

Dietary Supplement: Water-based vitamin D
Dietary Supplement: Oil-based vitamin D
Dietary Supplement: Vitamin D capsules

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT03810261
VITAD-01-2018 Part 2

Details and patient eligibility

About

The efficiency of different vitamin D formulations in treating suboptimal vitamin D status in adult population will be determined. It will provide insights into the influence of formulation on vitamin D absorption.

A randomised controlled intervention trial will be conducted on at least 72 subjects (18-65 years) with suboptimal Vitamin D status. Subjects will be selected from a pool of subjects in Part 1 of the study, after completion of winter sampling.

Study subjects will be randomised into four study groups (at least 18 subjects per study group). Three different treatments will be compared with a control group, which will not receive any supplemental Vitamin D. The three tested Vitamin D preparations in the treatment groups will be (A) oil-based VALENS vitamin D; (B) water-based VALENS vitamin D; and (C) Vitamin D capsules with starch-adsorbed vitamin D (powder). All these products are commercially available. Prior to study, actual level of vitamin D will be determined using appropriate analytical method. The treatment will be with 1000 IU Vitamin D per day, for two months, in all three groups. Second serum vitamin D level will be determined on last day of the treatment, and compared with pre-treatment vitamin D level.

Enrollment

105 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • vitamin D suboptimal status
  • Signed Informed consent form (ICF),
  • Caucasian race
  • Age between 18 and 65 years at the time of the signature of Informed consent form (ICF),
  • Willingness to avoid a consumption of any food supplements containing Vitamin D during the study, except the ones prescribed by the study researchers, and to avoid use of solarium or other artificial UVB sources
  • Willingness to follow all study procedures

Exclusion criteria

  • Pregnancy or breastfeeding,
  • Known or suspected allergy to any ingredient of the tested products in Part 2,
  • Pronounced avoidance of sunshine (eg reporting of allergy to the sun)
  • Use of food supplements containing Vitamin D or fish oil or omega 3 fatty acids in last three months prior to inclusion,
  • Special dietary habits used by a small part of the population (veganism, low-carb high-fat (LCHF) diet, caloric restriction diet, note: vegetarians are not excluded)
  • Diets prescribed by the medical profession
  • Disorders of the kidneys, thyroid, digestive tract, osteoporosis and other bone diseases, skin diseases
  • Other diseases and conditions that affect the absorption and synthesis of vitamin D
  • Exposure to stronger sunlight in the last three months prior to engaging in a survey (travel to countries with stronger sunshine, use of solarium),
  • The consumption of margarine or plant substitutes for milk / milk products several times a day, as these foods are most often enriched with vitamin D,
  • Visiting the solarium in the last three months before joining the survey,
  • Mental incapacity that precludes adequate understanding or cooperation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

105 participants in 4 patient groups

Oil-based vitamin D group
Experimental group
Description:
Oil-based vitamin D, 1000 IU/day for 8 weeks
Treatment:
Dietary Supplement: Oil-based vitamin D
Water-based vitamin D group
Experimental group
Description:
Water-based vitamin D, 1000 IU/day for 8 weeks
Treatment:
Dietary Supplement: Water-based vitamin D
Vitamin D capsules group
Experimental group
Description:
Vitamin D capsules with starch-adsorbed vitamin D (powder), 1000 IU/day for 8 weeks
Treatment:
Dietary Supplement: Vitamin D capsules
Control group
No Intervention group
Description:
This group will receive no intervention.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems